GBI 0.00% 16.0¢ genera biosystems limited

TTH - the Gates Foundation test is only aimed at second / third...

  1. 880 Posts.
    TTH - the Gates Foundation test is only aimed at second / third world markets. It is a competitor for PLT's Truscreen product (and could be partnered with Cerviscreen samples) rather than for highly sophisticated HPV tests like the existing Qiagen / Third Wave / genera offerings.
 
watchlist Created with Sketch. Add GBI (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.